[MP-202406 ] Tovorafenib (Glioma)
Last updated 18.06.2026
Project no.:
MP-202406
Report type:
Joint Clinical Assessment, JCA
Status:
Commission completed
Department/Division:
Drug Assessment
Topic:
Cancer
Indication:
Treatment of paediatric low-grade glioma (LGG)
Note:
This Joint Clinical Assessment (JCA) is being conducted in cooperation with the NCPE (National Centre for Pharmacoeconomics) Ireland.
The joint clinical assessment will be published on the European Commission’s website: health.ec.europa.eu/publications/joint-clinical-assessment-report-tovorafenib-ojemda_en
Further background information can be found here: European health technology assessment
| Stage | Date |
|---|---|
| Start | 1st quarter, 2025 |
| voraussichtlicher Abschluss | 2nd quarter, 2026 |